28/06/2024

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

28/06/2024

Jun 28, 2024, 13:32 | Societies
Updated results from the TRANSMET trial at ESMOGI24
ESMO shared on X: "ESMOGI24: Updated results from the TRANSMET trial showed that chemotherapy combined…
Jun 28, 2024, 13:17 | Blog
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
Zainab Shinkafi-Bagudu shared a post on LinkedIn:               . "Following…
Jun 28, 2024, 13:15 | Insight
The clinical utility of liquid biopsies detecting ctDNA in guiding treatment for patients with mCRC - ESMO
ESMO (European Society for Medical Oncology) shared on LinkedIn: "Data from two presentations at ESMOGI24…
Jun 28, 2024, 13:09 | Insight
Vittorio Studiale: Impressive pathological response rate with neoadjuvant BOT/BAL in MSS CRC
Vittorio Studiale, Medical Oncology Resident at University Hospital of Pisa, shared on X: "Impressive pathological…
Jun 28, 2024, 13:00 | Insight
Cathy Eng: Agenus with very promising data in early MSI-s/MSI-H colon cancer
Cathy Eng shared on X/Twitter: "Bot/Bal immunotherapy in colon cancer NEST 1/2. Agenus with very…
Jun 28, 2024, 12:53 | Insight
Myeloma Paper of the Day, June 28th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: "Myeloma Paper of the Day: A deep learning…
Jun 28, 2024, 12:50 | Insight
AI model may yield better outcomes for prostate cancer - UCLA Health
Using AI assistance for identifying cancerous tissue was 45 times more accurate than doctors’ measurements…
Jun 28, 2024, 12:46 | Blog
The partnership between UICC and Tradition Genève 1959 will enable access to early breast cancer detection services for women
Union for International Cancer Control (UICC) shared a post by Tradition Genève 1959 on LinkedIn,…
Jun 28, 2024, 12:37 | Blog
Devika Das: A whole new Pandora’s box of toxicities with the advent of check point inhibitors
Devika Das, Medical Director at Parexel, recently shared on LinkedIn:   . “It definitely takes a…
Jun 28, 2024, 12:35 | Blog
Over €14 M to Advance Development of Tacalyx's Cancer Therapeutics Targeting TACAs
Tacalyx, a privately held biotech company focused on developing novel anti-TACA (Tumor Associated Carbohydrate Antigens)…
All: 88 Posts: 31 - 40